Intelligent Bio Solutions Cash Flow Statement Analysis

Operating, investing, and financing activities in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Intelligent Bio Solutions Inc. (INBS) - Annual data in millions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec 2025Jun 2024Jun 2023Jun 2022Jun 2021
Operating Activities
Net Income-10.60-10.16-10.66-8.31-7.06
Depreciation & Amortization1.211.210.970.000.00
Stock Based Compensation0.240.230.260.000.00
Change in Working Capital-0.72-0.70-0.702.44-3.92
Change in Accounts Receivable-2.86-0.14-0.290.000.00
Change in Inventory0.140.20-0.350.000.00
Change in Accounts Payable0.00-0.630.080.24-0.97
Change in Other Working Capital2.00-0.14-0.222.54-3.97
Other Operating Activities0.20-0.163.062.54-0.46
Net Cash from Operating Activities-9.68-9.57-7.38-3.36-11.30
Investing Activities
Capital Expenditures-0.23-0.22-0.51-0.380.00
Acquisitions0.000.00-0.190.000.00
Purchases of Investments0.000.000.00-0.500.00
Sales/Maturities of Investments0.00-0.22-0.51-0.880.00
Other Investing Activities0.00-0.22-0.51-0.500.00
Net Cash from Investing Activities-0.23-0.22-0.69-0.880.00
Financing Activities
Common Stock Issued4.5914.56-0.520.0022.11
Common Stock Repurchased0.000.00-0.010.000.00
Other Financing Activities0.010.00-0.820.000.51
Net Cash from Financing Activities4.6014.561.440.0023.40
Summary
Effect of Forex Changes on Cash0.030.00-0.06-0.100.04
Net Change in Cash-5.284.77-6.64-4.2412.15
Cash at Beginning of Period6.301.548.2412.570.43
Cash at End of Period1.026.301.548.2412.57
Free Cash Flow-9.91-9.79-7.38-3.74-11.30
Supplemental Disclosures
Interest Paid0.000.000.000.000.19